Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival

Affiliations

• ¹ Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany.
• ² St Anna Children's Hospital and Children's Cancer Research Institute, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
• ³ Pediatric Hematology/Oncology, University of Zurich, Zurich, Switzerland.
• ⁴ Department of Pediatrics, Jena University Hospital, Jena, Germany.
• ⁵ Department of Pediatric Hematology-Oncology, University of Duisburg-Essen, Essen, Germany.
• ⁶ Department of Pediatric Oncology and Hematology, Medical School, Saarland University, Homburg, Germany.
• ⁷ Pediatric Hematology, Oncology and Hemostaseology, University Children's Hospital of Frankfurt/Main, Goethe-University Frankfurt/Main, Frankfurt/Main, Germany.
• ⁸ Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany.
• ⁹ Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Czech Pediatric Hematology Working Group (CPH), Prague, Czech Republic.